We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

136 hedge funds and large institutions have $370M invested in Anavex Life Sciences in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 29

7% more funds holding

Funds holding: 127 → 136 (+9)

5% more call options, than puts

Call options by funds: $19M | Put options by funds: $18.2M

2.64% less ownership

Funds ownership: 29.86% → 27.22% (-2.6%)

25% less capital invested

Capital invested by funds: $495M → $370M (-$125M)

Holders
136
Holders Change
+9
Holders Change %
+7.09%
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
29
Closed
17
Calls
$19M
Puts
$18.2M
Net Calls
+$840K
Net Calls Change
+$667K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.83M
2
Charles Schwab
Charles Schwab
California
+$6.77M
3
PC
Pier Capital
Connecticut
+$5.5M
4
UBS Group
UBS Group
Switzerland
+$3.44M
5
Nomura Holdings
Nomura Holdings
Japan
+$2.99M

Top Sellers

1
GLA
Great Lakes Advisors
Illinois
-$15.5M
2
Invesco
Invesco
Georgia
-$11.2M
3
First Trust Advisors
First Trust Advisors
Illinois
-$4.07M
4
EI
EAM Investors
California
-$4.06M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$79.6M +$2.4M +120,633 +3%
State Street
2
State Street
Massachusetts
$74.8M +$1.86M +93,447 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$71.6M +$6.83M +343,379 +9%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$21.5M +$807K +40,537 +4%
Northern Trust
5
Northern Trust
Illinois
$12.3M -$143K -7,179 -1%
Charles Schwab
6
Charles Schwab
California
$8.96M +$6.77M +340,353 +214%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$8.84M -$3.86M -193,833 -28%
PC
8
Pier Capital
Connecticut
$4.96M +$5.5M +276,183 New
Morgan Stanley
9
Morgan Stanley
New York
$4.48M -$444K -22,286 -8%
N
10
Nuveen
North Carolina
$4.05M -$182K -9,150 -4%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$3.9M -$870K -43,691 -17%
Jane Street
12
Jane Street
New York
$3.66M -$27.1K -1,361 -0.7%
UBS Group
13
UBS Group
Switzerland
$3.21M +$3.44M +172,594 +2,689%
Rafferty Asset Management
14
Rafferty Asset Management
New York
$2.99M -$33K -1,657 -1%
Citigroup
15
Citigroup
New York
$2.83M -$3.46M -173,627 -52%
Deutsche Bank
16
Deutsche Bank
Germany
$2.78M +$1.27K +64 +0%
Voloridge Investment Management
17
Voloridge Investment Management
Florida
$2.71M -$673K -33,829 -18%
Nomura Holdings
18
Nomura Holdings
Japan
$2.69M +$2.99M +150,000 New
Swiss National Bank
19
Swiss National Bank
Switzerland
$2.63M – – –
Millennium Management
20
Millennium Management
New York
$2.29M +$565K +28,391 +29%
Goldman Sachs
21
Goldman Sachs
New York
$1.93M +$349K +17,557 +19%
KPWS
22
Kestra Private Wealth Services
Texas
$1.8M +$2M +100,300 New
Wells Fargo
23
Wells Fargo
California
$1.75M +$136K +6,839 +8%
State of Wisconsin Investment Board
24
State of Wisconsin Investment Board
Wisconsin
$1.64M +$9.95K +500 +0.6%
AllianceBernstein
25
AllianceBernstein
Tennessee
$1.6M – – –
1
2 3 4 5

AVXL Hedge Fund Activity: Q3 2021 in Review

136 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2021, worth a combined $370M — down 25% from $495M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AVXL positions and 17 closed out — a net gain of 11 holders — while 46 added to existing stakes and 29 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.83M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $15.5M sold.

  • 136 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2021, up from 127 in Q2 2021.
  • Funds reported $370M of Anavex Life Sciences stock for Q3 2021, down 25% quarter-over-quarter.
  • 28 funds opened new Anavex Life Sciences positions in Q3 2021 and 17 closed out, a net change of +11 holders.
  • The largest Anavex Life Sciences buyer in Q3 2021 was Vanguard Group, an estimated $6.83M added.
  • The largest Anavex Life Sciences seller in Q3 2021 was Great Lakes Advisors, an estimated $15.5M sold.

Based on aggregated 13F filings for Q3 2021.